Cart
sales@molnova.com
PEPA
CAS No. 141286-78-4
PEPA( —— )
Catalog No. M26365 CAS No. 141286-78-4
PEPA is an allosteric AMPA receptors modulator; binds to the GluA2o and GluA3o LBDs and can be utilized as an indicator of AMPA receptor heterogeneity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 32 | In Stock |
|
| 5MG | 30 | In Stock |
|
| 10MG | 46 | In Stock |
|
| 25MG | 101 | In Stock |
|
| 50MG | 193 | In Stock |
|
| 100MG | 287 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePEPA
-
NoteResearch use only, not for human use.
-
Brief DescriptionPEPA is an allosteric AMPA receptors modulator; binds to the GluA2o and GluA3o LBDs and can be utilized as an indicator of AMPA receptor heterogeneity.
-
DescriptionPEPA is an allosteric AMPA receptors modulator; binds to the GluA2o and GluA3o LBDs and can be utilized as an indicator of AMPA receptor heterogeneity.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetiGluR
-
RecptorPDE4
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number141286-78-4
-
Formula Weight402.43
-
Molecular FormulaC16H16F2N2O4S2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (124.24 mM)
-
SMILESNC(=O)COc1c(F)cc(SCCNS(=O)(=O)c2ccccc2)cc1F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Zhao Y, Zhang HT, O'Donnell JM. Inhibitor binding to type 4 phosphodiesterase (PDE4) assessed using [3H]piclamilast and [3H]rolipram. J Pharmacol Exp Ther. 2003 May;305(2):565-72. doi: 10.1124/jpet.102.47407. Erratum in: J Pharmacol Exp Ther. 2003 Dec;307(3):1243.
molnova catalog
related products
-
Perampanel
Perampanel (E2007) is a novel, orally active, noncompetitive AMPA receptor (AMPAR) antagonist with IC50 of 93 nM.
-
Dasolampanel
Dasolampanel (NGX426) is an orally bioavailable, competitive antagonist of the AMPA-kainate receptors for the treatment of chronic pain conditions including neuropathic pain and migraine.
-
Rislenemdaz hydrochl...
Rislenemdaz (MK 0657;CERC 301) is a potent, orally bioavailable, brain‐penetrant, NR2B-selective NMDA receptor (GluN2B) antagonist with Ki and IC 50 of 8.1 nM and 3.6 nM respectively.
